FDA Eyes New Fees For Makers Of Over-The-Counter Drugs
The U.S. Food and Drug Administration on Tuesday said it is interested in collecting fees from manufacturers of over-the-counter drugs in order to address a "critically under-resourced" area of regulatory oversight....To view the full article, register now.
Already a subscriber? Click here to view full article